-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Contrary to what you learned in school, transporting oxygen is not the only function of red blood cells
Nilam Mangalmurti is an intensive care doctor and researcher at the University of Pennsylvania.
In the past decade, although Mangalmurti's team discovered that blood transfusion and red blood cell surface circulation are not only functions of hemoglobin, but actually have other functions
After publishing the paper in 2018, the researchers asked some unanswered questions
The changes in surface protein levels are unexpected, because red blood cells do not have a nucleus, so they cannot change their gene expression and corresponding protein levels based on environmental cues
Mangalmurti and his colleagues also used antibody staining to prove that these morphological changes masked the CD47 antigen displayed by red blood cells
After DNA processing, human red blood cells will change shape
Removal of red blood cells from the blood circulation also seems to have an effect on anemia, which is common in patients in the intensive care unit
Mangalmurti explained that under normal circumstances, red blood cells survive in the blood circulation for 120 days, occasionally extracting DNA and then being eliminated
"The role of red blood cells in pathogen perception is often overlooked," said Sizun Jiang of Harvard Medical School.
Sugimura, who was not involved in the study, said: "This paper shows that red blood cells can be used as innate immune cells," not just oxygen transport cells
Another potential application is "development of early biomarkers for systemic inflammation
Mangalmurti agrees that there is potential for diagnosis and treatment